Back to News
Market Impact: 0.35
Eurobio Scientific: EB Development, actionnaire majoritaire d’Eurobio Scientific, annonce son intention de déposer une offre publique de retrait suivie d'un retrait obligatoire, au prix de 25,30 € par action
Source: GlobeNewswire
M&A & RestructuringCompany Fundamentals
EB Development, Eurobio Scientific’s majority shareholder, intends to launch a public buyout offer followed by a compulsory squeeze-out at €25.30 per share. The transaction would take Eurobio Scientific private, providing minority shareholders with a defined cash exit price.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
ALERS0.65
More News
- Japan’s corporate leaders sound alarm over weak yen — even dollar-earners are voicing concerns
- Fed hikes again - an AI-Picked insurer is still cashing in
- Berkshire May Boost Japan Trading House Holdings, Itochu Says
- Fed delivers its first hike in 3 years. Plus, what's moving Starbucks and GE Vernova
- Berkshire may boost holdings in Japan’s trading houses- Bloomberg
- The Competition's Response to Tesla Robotaxi Day
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AI Research Systems for Hedge Funds: A Pilot Design
- Weekly Update: New Reporting Features, UI Improvements, and Chat Optimizations